Opthea to Appoint Dr Jeremy Levin as Chairman of the Board

Opthea Limited, a clinical stage biopharmaceutical company developing a novel therapy to treat highly prevalent and progressive retinal diseases, is pleased to announce that Jeremy Levin, DPhil, MB BChir will be appointed to the Company’s Board of Directors, effective October 12, 2020.